https://clinicaltrials.gov/ct2/show/NCT03781479?type=Intr&cond=spinal+muscular+atrophy&phase=0124&lupd_s=07%2F10%2F2020&lupd_d=14&sort=nwst
STUDY TITLE:
Controlled Trial to Evaluate Amifampridine Phosphate in Spinal Muscular Atrophy Type 3 Patients
DESCRIPTION:
Condition: Muscular Atrophy, Spinal
Interventions: Drug: Amifampridine Phosphate; Drug: Placebo Oral Tablet
Sponsor: Catalyst Pharmaceuticals, Inc.
Completed
CLINICALTRIALS.GOV IDENTIFIER:
NCT03781479
FIRST POSTED:
Thu, 20 Dec 2018 12:00:00 EST
LAST UPDATE POSTED:
07/24/20 06:53AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03781479?type=Intr&cond=spinal+muscular+atrophy&phase=0124&lupd_s=07%2F10%2F2020&lupd_d=14&sort=nwst
